Summary
Overview
Work History
Education
Skills
Accomplishments
Certification
Additional Information
Webinars
Languages
Timeline
Generic

Joshua Burgess, Ph.D.

Sun Prairie,WI

Summary

Experienced leader in assay development with a consistent track record of excellence, developing and commercializing, next generation sequencing products. Previous experience includes a well established track record of on time delivery of high quality products within established budgets. Also, an accomplished people manager, and leader of leaders, with a large team of direct reports across multiple time zones, and extensive experience leading very large cross-functional teams in New Product Introduction. Additional skills include technical leadership, project management, resolving conflict, communication to all levels of executive leadership, providing even-handed guidance through complex challenges, and a polished capacity to proactively identify and solve potentially intractable problems.

Overview

12
12
years of professional experience
1
1
Certification

Work History

Associate Director of Scientific Research

Illumina
07.2022 - Current
  • Currently leading a team of Research and Development scientists (12 direct reports)
  • System integration of end-to-end solutions in assay development, platform integration, and software development
  • Core Team Lead for multiple parallel product launches of Research Use Only methods in assay development with budget greater than $30M and revenue projections of >$400M over the next 5 years
  • Functional team leadership responsible for on-time, high quality execution of deliverables for greater than 100 individuals
  • Highly collaborative, intuitive team leader capable of maintaining an unflappable approach in high stress situations
  • Continuous cross-functional interaction between all teams required for product launch, including Research and Development, Marketing, Quality Assurance, Service and Support, and Operations teams
  • Logistical planning of budget, resource, and equipment needs necessary for successful creation, optimization, and implementation of methods
  • Responsible for product launch, and on market interactions with diverse, global institutions in their testing and validation of library preparation method
  • Collaborated with Quality leadership to re-develop QMS and accelerate RUO product development pipeline to maximize product revenue

Senior Manager, Scientific Research

Illumina
04.2020 - 07.2022
  • Core Team Lead for RUO, LDT, and IVD product development projects
  • IVD compliant product development targeted at Rare and Undiagnosed Genetic Diseases (RUGD)
  • Led Risk Management planning and execution of clinical infectious disease product intended for strain identification of COVID-19 (COVID-SEQ)
  • Responsible for leading executive steering committee targeted at expediting the product development pipeline for the creation of RUO and IVD products
  • Coordinated budget, resources, and timelines for projects with budgets up to $10M and projected 5-year revenues exceeding $100M

Scientist 1 to Manager

Illumina
05.2013 - 04.2020
  • Lead project manager in RUO assay development for a project with a $3M budget and >$100M in 5-year revenue
  • Lead project manager collaborating with manufacturing team to develop sustainable enzyme processes to keep up with surging product demand
  • Advanced super user training in Agile and SAP to improve traceability of all documentation associated with product development
  • Technical lead in RUO assay development
  • Lead presenter in multiple internal and external forums, including post-launch collaborative webinar with DNA Genotek, attended by KOLs in the field of genomics

Scientist, Catalyst Development

Gevo Incorporated
05.2012 - 05.2013
  • Molecular biologist responsible for yeast strain engineering
  • Strains designed for expression of isopropanol intended for utilization as a biofuel

Scientist, Gene Expression

Intrexon Corporation
05.2011 - 04.2012
  • Development of GMOs intended to block the expression of bruising-related genes in Agaricus bisporus

Education

Ph.D. - Biochemistry and Molecular Biology

Mayo Clinic College of Medicine
Rochester, MN
05.2008

Master of Science - Clinical Microbiology

University of Wisconsin-La Crosse
12.2003

Bachelor of Science - Biology With Environmental Science And Spanish

University of Wisconsin-La Crosse
05.2001

Skills

  • Project Management and Team Leader
  • Problem Solving complex scientific challenges with constrained budgets, equipment, and resources
  • Expert in leading a large, global, multi-functional team in product development from product inception to post launch surveillance
  • Expert in all facets of Product Development Process (PDP)-focused Quality Management Systems
  • Expert in Risk Management
  • Expert in Design Verification and Validation
  • Expert in launching products that require complex system integration
  • Technical expertise in Molecular Biology, Biochemistry, Clinical Microbiology, Medical Mycology, and Mycology
  • Accomplished public speaker and communicator
  • Highly collaborative personality with extensive experience in crucial conversations and development of personnel

Accomplishments

  • Previously led, or actively leading, launch of 7 products as Core Team Lead (4), Project Manager (2), or Technical Lead (1)
  • Ongoing PDP projects in development (RUO, Core Team Lead, 2 concurrent projects)
  • Successful product launches:
  • Illumina Complete Long Reads (RUO, Core Team Lead)
  • Illumina DNA PCR Free (RUO, Core Team Lead)
  • Internal Sustaining Project for continued supply continuity (Lead Project Manager)
  • Illumina DNA Prep (RUO, Lead Project Manager)
  • Truseq DNA Rapid Exome (RUO, Technical Lead)
  • Additional accomplishments:
  • Execution of large strategic initiatives, including leading multiple executive steering committees in re-development of quality management system to meet strategic timelines
  • Extensive training in crucial conversations, management of direct reports, Critical Parameter Management, and DoE


Certification

  • Bruinsma, SB, JW Burgess, D Schlingman, et al. 2018. Bead linked transposomes enable a normalization free workflow for NGS library preparation. BMC Genomics. Oct 1; 19(1).


  • Burgess JW, Kottom TJ, and AH Limper. 2011. Pneumocystis carinii binding to host lung epithelial cells and extracellular matrixes activates PCSTE20p and subsequent phosphorylation of the downstream cell wall remodeling kinase PCCBK1p: Evidence for a unique signaling pathway. Infection and Immunity. Oct 79(10):4157-64.


  • Pfister JR, Archer JR, Hersil S, Boers T, Reed KD, Meece JK, Anderson JL, Burgess JW, Sullivan TD, Klein BS, Wheat JL, and JP Davis. 2011. Non-Rural Point Source Blastomycosis Outbreak Near a Yard Waste Collection Site. Clinical Medicine and Research. June 9(2): 57-65.


  • Burgess JW, Kottom TJ, Lamont JD, Baden EM, Ramirez-Alvarado M, and AH Limper. 2009. The Pneumocystis Meiotic PCRan1p Kinase Exhibits Unique Temperature Regulated Activity. American Journal of Respiratory Cell and Molecular Biology. Dec (41): 714-721.


  • Burgess JW, Kottom TJ, and AH Limper. 2008. Presence of a conserved meiotic pathway in Pneumocystis carinii. Infection and Immunity. Jan (76); 417-425.


  • Burgess JW, Schwan WR, and TJ Volk. 2006. PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples. Medical Mycology. Vol 44; pp. 741-748.


  • Agger W., D. Andes, and JW Burgess. 2003. Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine. Clinical Infectious Diseases. ePub

Additional Information

  • Erin Bomati, JW Burgess, et al. Modified Transposases For Improved Insertion Sequence Bias and Increased DNA Input Tolerance. 2019 US Patent US10544403B2


  • H Meinholz, D Gerhardt, JW Burgess, et al. Preparation of Long Read Nucleic Acid Libraries. Provisional Patent Filed 2023.

Webinars

  • Presented collaborative webinar between DNA Genotek and Illumina entitled, "High Quality Libraries for Human WGS with Direct Saliva Input." 2018.

Languages

Spanish
Full Professional

Timeline

Associate Director of Scientific Research

Illumina
07.2022 - Current

Senior Manager, Scientific Research

Illumina
04.2020 - 07.2022

Scientist 1 to Manager

Illumina
05.2013 - 04.2020

Scientist, Catalyst Development

Gevo Incorporated
05.2012 - 05.2013

Scientist, Gene Expression

Intrexon Corporation
05.2011 - 04.2012

Ph.D. - Biochemistry and Molecular Biology

Mayo Clinic College of Medicine

Master of Science - Clinical Microbiology

University of Wisconsin-La Crosse

Bachelor of Science - Biology With Environmental Science And Spanish

University of Wisconsin-La Crosse
Joshua Burgess, Ph.D.